Eden Research (LON:EDEN) Shares Down 6.8% – Here’s Why

Eden Research plc (LON:EDENGet Free Report) traded down 6.8% on Friday . The company traded as low as GBX 3.17 ($0.04) and last traded at GBX 3.17 ($0.04). 1,305,808 shares traded hands during mid-day trading, an increase of 156% from the average session volume of 509,970 shares. The stock had previously closed at GBX 3.40 ($0.05).

Eden Research Price Performance

The firm has a market capitalization of £16.89 million, a P/E ratio of -11.09 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80. The business has a 50 day simple moving average of GBX 3.53 and a two-hundred day simple moving average of GBX 3.33.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.

Featured Stories

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.